Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” Ligands-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” Ligands

Published:2001-02 Issue:2 Volume:281 Page:444-451
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Di Marzo V.,Bisogno T.,De Petrocellis L.,Brandi I.,Jefferson R.G.,Winckler R.L.,Davis J.B.,Dasse O.,Mahadevan A.,Razdan R.K.,Martin B.R.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference26 articles.

1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor;Devane;Science,1992

2. Pharmacology of cannabinoid CB1 and CB2 receptors;Pertwee;Pharmacol. Ther.,1997

3. Endocannabinoids;Mechoulam;Eur. J. Pharmacol.,1998

4. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide;Zygmunt;Nature,1999

5. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1);Smart;Br. J. Pharmacol.,2000

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators;European Journal of Medicinal Chemistry;2024-12

2. A systematic review of novel cannabinoids and their targets: Insights into the significance of structure in activity;European Journal of Pharmacology;2024-08

3. The Multicomponent Passerini Reaction as a Means of Accessing Diversity in Structure, Activity and Properties: Soft and Hard Vanilloid/Cannabinoid Modulators;2024

4. Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges;Frontiers in Immunology;2023-12-04

5. Impact of Cannabinoid Receptors in the Design of Therapeutic Agents against Human Ailments;Current Topics in Medicinal Chemistry;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3